The suppression of innate immune response by human rhinovirus C

Biochemical and Biophysical Research Communications

Volumn 490, Issue 1, 2017, Pages 22-28

  Pang, Li li ^a   Yuan, Xin hui ^b   Shao, Chang sheng ^c   Li, Mao zhong ^a,d   Wang, Ying ^a,e   Wang, Hui min ^a,e   Xie, Guang cheng ^a,f   Xie, Zhi ping ^a   Yuan, Yue ^a,e   Zhou, Dong mei ^a   Sun, Xiao man ^a   Zhang, Qing ^a   Xin, Yan ^e   Li, Dan di ^a   Duan, Zhao jun ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b LANZHOU UNIVERSITY   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^d Institute for Immunization and Prevention   (China)

^e INNER MONGOLIA MEDICAL UNIVERSITY   (China)

^f CHENGDE MEDICAL COLLEGE   (China)

Author keywords

3C protein; Interferon response; MAVS; Rhinovirus C; RIG I signaling pathway

Indexed keywords

BETA INTERFERON; CASPASE; MESSENGER RNA; INTERFERON;

ARTICLE; BRONCHUS EPITHELIUM; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS C; HUMAN TISSUE; INNATE IMMUNITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RHINOVIRUS INFECTION; SIGNAL TRANSDUCTION; HEK293 CELL LINE; HELA CELL LINE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; RHINOVIRUS;

HEK293 CELLS; HELA CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INTERFERON TYPE I; RHINOVIRUS;

EID: 85020287446     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.05.169     Document Type: Article

References (25)

1. Arden, K.E., Faux, C.E., O'Neill, N.T., McErlean, P., Nitsche, A., Lambert, S.B., Nissen, M.D., Sloots, T.P., Mackay, I.M., Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003, Journal of clinical virology. official Publ. Pan Am. Soc. Clin. Virol. 47 (2010), 219–223.
2. Anderson, H.M., Lemanske, R.F. Jr., Evans, M.D., Gangnon, R.E., Pappas, T.E., Grindle, K.A., Bochkov, Y.A., Gern, J.E., Jackson, D.J., Assessment of wheezing frequency and viral etiology on childhood and adolescent asthma risk. J. allergy Clin. Immunol. 139 (2017), 692–694.
3. Arden, K.E., McErlean, P., Nissen, M.D., Sloots, T.P., Mackay, I.M., Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J. Med. Virol. 78 (2006), 1232–1240.
4. Lee, W.M., Lemanske, R.F. Jr., Evans, M.D., Vang, F., Pappas, T., Gangnon, R., Jackson, D.J., Gern, J.E., Human rhinovirus species and season of infection determine illness severity. Am. J. Respir. Crit. care Med. 186 (2012), 886–891.
5. Mak, R.K., Tse, L.Y., Lam, W.Y., Wong, G.W., Chan, P.K., Leung, T.F., Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children. Pediatr. Infect. Dis. J. 30 (2011), 749–753.
6. Khetsuriani, N., Lu, X., Teague, W.G., Kazerouni, N., Anderson, L.J., Erdman, D.D., Novel human rhinoviruses and exacerbation of asthma in children. Emerg. Infect. Dis. 14 (2008), 1793–1796.
7. Bizzintino, J., Lee, W.M., Laing, I.A., Vang, F., Pappas, T., Zhang, G., Martin, A.C., Khoo, S.K., Cox, D.W., Geelhoed, G.C., McMinn, P.C., Goldblatt, J., Gern, J.E., Le Souef, P.N., Association between human rhinovirus C and severity of acute asthma in children. Eur. Respir. J. 37 (2011), 1037–1042.
8. Miller, E.K., Edwards, K.M., Weinberg, G.A., Iwane, M.K., Griffin, M.R., Hall, C.B., Zhu, Y., Szilagyi, P.G., Morin, L.L., Heil, L.H., Lu, X., Williams, J.V., New Vaccine Surveillance, N., A novel group of rhinoviruses is associated with asthma hospitalizations. J. allergy Clin. Immunol. 123 (2009), 98–104 e101.
9. Xiang, Z., Gonzalez, R., Xie, Z., Xiao, Y., Chen, L., Li, Y., Liu, C., Hu, Y., Yao, Y., Qian, S., Geng, R., Vernet, G., Paranhos-Baccala, G., Shen, K., Jin, Q., Wang, J., Human rhinovirus group C infection in children with lower respiratory tract infection. Emerg. Infect. Dis. 14 (2008), 1665–1667.
10. Brooks, G.D., Buchta, K.A., Swenson, C.A., Gern, J.E., Busse, W.W., Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. Am. J. Respir. Crit. care Med. 168 (2003), 1091–1094.
11. Kotla, S., Peng, T., Bumgarner, R.E., Gustin, K.E., Attenuation of the type I interferon response in cells infected with human rhinovirus. Virology 374 (2008), 399–410.
12. Wark, P.A., Johnston, S.L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., Holgate, S.T., Davies, D.E., Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201 (2005), 937–947.
13. Contoli, M., Message, S.D., Laza-Stanca, V., Edwards, M.R., Wark, P.A., Bartlett, N.W., Kebadze, T., Mallia, P., Stanciu, L.A., Parker, H.L., Slater, L., Lewis-Antes, A., Kon, O.M., Holgate, S.T., Davies, D.E., Kotenko, S.V., Papi, A., Johnston, S.L., Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 12 (2006), 1023–1026.
14. Bochkov, Y.A., Palmenberg, A.C., Lee, W.M., Rathe, J.A., Amineva, S.P., Sun, X., Pasic, T.R., Jarjour, N.N., Liggett, S.B., Gern, J.E., Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat. Med. 17 (2011), 627–632.
15. Hao, W., Bernard, K., Patel, N., Ulbrandt, N., Feng, H., Svabek, C., Wilson, S., Stracener, C., Wang, K., Suzich, J., Blair, W., Zhu, Q., Infection and propagation of human rhinovirus C in human airway epithelial cells. J. Virol. 86 (2012), 13524–13532.
16. Wang, Q., Nagarkar, D.R., Bowman, E.R., Schneider, D., Gosangi, B., Lei, J., Zhao, Y., McHenry, C.L., Burgens, R.V., Miller, D.J., Sajjan, U., Hershenson, M.B., Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 183 (2009), 6989–6997.
17. Slater, L., Bartlett, N.W., Haas, J.J., Zhu, J., Message, S.D., Walton, R.P., Sykes, A., Dahdaleh, S., Clarke, D.L., Belvisi, M.G., Kon, O.M., Fujita, T., Jeffery, P.K., Johnston, S.L., Edwards, M.R., Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog., 6, 2010, e1001178.
18. Wang, Q., Miller, D.J., Bowman, E.R., Nagarkar, D.R., Schneider, D., Zhao, Y., Linn, M.J., Goldsmith, A.M., Bentley, J.K., Sajjan, U.S., Hershenson, M.B., MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog., 7, 2011, e1002070.
19. Drahos, J., Racaniello, V.R., Cleavage of IPS-1 in cells infected with human rhinovirus. J. Virol. 83 (2009), 11581–11587.
20. Matthews, D.A., Smith, W.W., Ferre, R.A., Condon, B., Budahazi, G., Sisson, W., Villafranca, J.E., Janson, C.A., McElroy, H.E., Gribskov, C.L., et al. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77 (1994), 761–771.
21. Stoker, D., Kiernat, J., Gauntt, C., Interferon induction by rhinoviruses and effect of interferon on rhinovirus yields in human cell lines. Proc. Soc. Experim. Biol. Med. Soc. Exp. Biol. Med. 143 (1973), 23–27.
22. Khaitov, M.R., Laza-Stanca, V., Edwards, M.R., Walton, R.P., Rohde, G., Contoli, M., Papi, A., Stanciu, L.A., Kotenko, S.V., Johnston, S.L., Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 64 (2009), 375–386.
23. Nakagome, K., Bochkov, Y.A., Ashraf, S., Brockman-Schneider, R.A., Evans, M.D., Pasic, T.R., Gern, J.E., Effects of rhinovirus species on viral replication and cytokine production. J. allergy Clin. Immunol. 134 (2014), 332–341.
24. Mukherjee, A., Morosky, S.A., Delorme-Axford, E., Dybdahl-Sissoko, N., Oberste, M.S., Wang, T., Coyne, C.B., The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog., 7, 2011, e1001311.
25. Deszcz, L., Gaudernak, E., Kuechler, E., Seipelt, J., Apoptotic events induced by human rhinovirus infection. J. general Virol. 86 (2005), 1379–1389.